<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="51349">Polyamine</z:chebi> metabolism is an intriguing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> therapeutic target </plain></SENT>
<SENT sid="1" pm="."><plain>The present study was designed to assess the synergistic antitumor effects of NPC-16, a novel <z:chebi fb="0" ids="51349">polyamine</z:chebi> naphthalimide conjugate, with <z:chebi fb="0" ids="41423">celecoxib</z:chebi> and to elucidate the mechanism of these effects on human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Cell proliferation was assessed by the <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="3" pm="."><plain>Cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and mitochondria membrane potential were evaluated by high content screening analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Intracellular <z:chebi fb="0" ids="51349">polyamine</z:chebi> content was detected by HPLC </plain></SENT>
<SENT sid="5" pm="."><plain>Protein expression was detected by western blot analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The co-treatment with <z:chebi fb="0" ids="41423">celecoxib</z:chebi> enhanced NPC-16-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in HCT116 (COX-2 no expression), HT29 (COX-2 higher expression) and Caco-2 (COX-2 higher expression) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, which was mediated by the elevated NPC-16 uptake via the effect of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> on <z:chebi fb="0" ids="51349">polyamine</z:chebi> metabolism, including the up-regulated <z:chebi fb="0" ids="16610">spermidine</z:chebi>/<z:chebi fb="0" ids="15746">spermine</z:chebi> N(1)-acetyltransferase (SSAT) activity and reduced intracellular <z:chebi fb="0" ids="51349">polyamine</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain>The presence of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> does not result in obviously different effect on the NPC-16-triggered <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in diverse COX-2 expressed colorectal cell lines, suggesting that COX-2 was not one vital factor in the apoptotic mechanism </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, this synergistic <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was involved in the PKB/AKT signal pathway, Bcl-2 and caspase family members </plain></SENT>
<SENT sid="9" pm="."><plain>Z-VAD-FMK, a cell permeable pan caspase inhibitor, almost completely inhibited <z:chebi fb="0" ids="41423">celecoxib</z:chebi> and NPC-16 co-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, indicating that this <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was caspase dependent </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Co-treatment of <z:chebi fb="0" ids="41423">celecoxib</z:chebi> and NPC-16 could induce <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via COX-2-independent and caspase-dependent mechanisms </plain></SENT>
<SENT sid="11" pm="."><plain>The combination therapy with these agents might provide a novel therapeutic model for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>